TW202317091A - Water-in-oil composition for external use containing ascorbic acid and/or salt thereof - Google Patents

Water-in-oil composition for external use containing ascorbic acid and/or salt thereof Download PDF

Info

Publication number
TW202317091A
TW202317091A TW111137124A TW111137124A TW202317091A TW 202317091 A TW202317091 A TW 202317091A TW 111137124 A TW111137124 A TW 111137124A TW 111137124 A TW111137124 A TW 111137124A TW 202317091 A TW202317091 A TW 202317091A
Authority
TW
Taiwan
Prior art keywords
mass
oil
water
composition
ascorbic acid
Prior art date
Application number
TW111137124A
Other languages
Chinese (zh)
Other versions
TWI813460B (en
Inventor
北岡侑
山本仁見
Original Assignee
日商樂敦製藥股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商樂敦製藥股份有限公司 filed Critical 日商樂敦製藥股份有限公司
Publication of TW202317091A publication Critical patent/TW202317091A/en
Application granted granted Critical
Publication of TWI813460B publication Critical patent/TWI813460B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A61K8/894Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/18Antioxidants, e.g. antiradicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Toxicology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Provided is a water-in-oil composition for external use that contains ascorbic acid or a salt thereof. This prepared water-in-oil composition for external use contains: (A) at least one selected from the group consisting of ascorbic acid and an ascorbic acid salt; (B) propanediol; (C) an oil component; and (D) a silicone-based surfactant. This water-in-oil composition for external use has good stability.

Description

含有抗壞血酸以及/或是其鹽之油中水型外用組成物Water-in-oil composition for external use containing ascorbic acid and/or its salt

本發明係關於一種含有抗壞血酸以及或是其鹽之油中水型外用組成物。The present invention relates to a water-in-oil external composition containing ascorbic acid and its salt.

對於抗壞血酸,已知發揮抗炎效果、青春痘改善效果、美白效果、抗老化效果、抗氧化效果、由促進合成膠原蛋白等活體成分所帶來之細胞活化效果、抑制表皮角化細胞因紫外線所致之細胞毒殺(cytotoxic)、DNA(deoxyribonucleic acid;去氧核糖核酸)損傷之效果等各種效果,期待這些效果而被廣泛地用作皮膚外用劑。Ascorbic acid is known to exhibit anti-inflammatory effects, acne-improving effects, whitening effects, anti-aging effects, antioxidant effects, cell activation effects by promoting the synthesis of collagen and other living components, and inhibition of epidermal keratinocytes caused by ultraviolet rays. Various effects such as cytotoxic effect and DNA (deoxyribonucleic acid; deoxyribonucleic acid) damage effect are expected, and these effects are widely used as skin external preparations.

提供一種包含抗壞血酸且穩定性及使用感優異之外用組成物(例如,專利文獻1:WO2018/003850號公報)。 [先前技術文獻] [專利文獻] Provided is an external composition containing ascorbic acid and having excellent stability and usability (for example, Patent Document 1: WO2018/003850 A). [Prior Art Literature] [Patent Document]

[專利文獻1]WO2018/003850號公報。[Patent Document 1] WO2018/003850 publication.

[發明所欲解決之課題][Problem to be Solved by the Invention]

本發明的目的在於提供一種含有抗壞血酸以及或是其鹽之優異的油中水型外用組成物。 [用以解決課題之手段] The object of the present invention is to provide an excellent water-in-oil composition for external use containing ascorbic acid and a salt thereof. [Means to solve the problem]

乳霜劑、乳液係保濕性優異而被廣泛地用作例如化妝品之形態。根據本發明者等人之研究,確定含有抗壞血酸以及或是其鹽之製劑根據皮膚狀態有時存在刺激皮膚之問題。進而,本發明者等人注意到含有抗壞血酸以及或是其鹽之製劑的穩定性有時亦會產生問題。Creams and emulsions are excellent in moisturizing properties and are widely used, for example, in the form of cosmetics. According to the study of the inventors of the present invention, it has been confirmed that preparations containing ascorbic acid and its salts sometimes have a problem of skin irritation depending on the condition of the skin. Furthermore, the inventors of the present invention noticed that the stability of preparations containing ascorbic acid and its salts may sometimes cause problems.

本發明者等人為了解決本課題而反復進行了努力研究,結果發現,藉由含有(A)選自由抗壞血酸及抗壞血酸之鹽所組成之群組中的至少一種、(B)丙二醇、及(C)油分,可獲得優異的油中水型外用組成物,從而完成本發明。The inventors of the present invention have repeatedly conducted intensive studies to solve the present problem, and as a result, found that by containing (A) at least one selected from the group consisting of ascorbic acid and ascorbic acid salts, (B) propylene glycol, and (C ) oil component, an excellent water-in-oil type composition for external use can be obtained, thereby completing the present invention.

亦即,本發明提供下述揭示之油中水型外用組成物。 [1]一種油中水型外用組成物,含有:(A)選自由抗壞血酸及抗壞血酸之鹽所組成之群組中的至少一種;(B)丙二醇;(C)油分;及(D)聚矽氧系界面活性劑。 [2]如項1所記載之油中水型外用組成物,其中前述(A)選自由抗壞血酸及抗壞血酸之鹽所組成之群組中的至少一種的含量為1質量%至30質量%。 [3]如項1或2所記載之油中水型外用組成物,其中前述(B)丙二醇的含量為15質量%以上。 [4]如項1至3中任一項所記載之油中水型外用組成物,其中水的含量為10質量%以下。 [5]如項1至4中任一項所記載之油中水型外用組成物,其中前述(C)油分包含聚矽氧油。 [6]如項1至5中任一項所記載之油中水型外用組成物,進而含有低級醇。 [7]一種緩和油中水型外用組成物之皮膚刺激之方法,係藉由使(A)選自由抗壞血酸及抗壞血酸之鹽所組成之群組中的至少一種、(B)丙二醇、(C)油分、及(D)聚矽氧系界面活性劑共存,來緩和含有(A)選自由抗壞血酸及抗壞血酸之鹽所組成之群組中的至少一種之油中水型外用組成物之皮膚刺激。 [發明功效] That is, the present invention provides the water-in-oil type external composition disclosed below. [1] A water-in-oil type composition for external use, comprising: (A) at least one selected from the group consisting of ascorbic acid and ascorbic acid salts; (B) propylene glycol; (C) oil; and (D) polysilicone Oxygen-based surfactants. [2] The water-in-oil composition for external use according to item 1, wherein the content of at least one selected from the group consisting of ascorbic acid and salts of ascorbic acid is 1% to 30% by mass. [3] The water-in-oil composition for external use according to item 1 or 2, wherein the content of the aforementioned (B) propylene glycol is 15% by mass or more. [4] The water-in-oil composition for external use according to any one of items 1 to 3, wherein the water content is 10% by mass or less. [5] The water-in-oil composition for external use according to any one of items 1 to 4, wherein the (C) oil component contains silicone oil. [6] The water-in-oil composition for external use according to any one of items 1 to 5, further comprising a lower alcohol. [7] A method for alleviating skin irritation of a water-in-oil type composition for external use, comprising (A) at least one selected from the group consisting of ascorbic acid and a salt of ascorbic acid, (B) propylene glycol, (C) Coexistence of oil and (D) polysiloxane-based surfactants relieves skin irritation of the water-in-oil type external composition containing (A) at least one selected from the group consisting of ascorbic acid and ascorbic acid salts. [Efficacy of the invention]

藉由本發明,能夠提供一種皮膚刺激少的油中水型外用組成物。 藉由本發明,亦能夠提供一種穩定的油中水型外用組成物。 ADVANTAGE OF THE INVENTION According to this invention, the water-in-oil type external composition with little skin irritation can be provided. The present invention can also provide a stable water-in-oil type composition for external use.

本說明書中,含量的單位「質量%」與「g/100g」為同義。In this specification, the unit "mass %" and "g/100g" of content are synonymous.

[油中水型外用組成物] 本發明之油中水型外用組成物係含有(A)選自由抗壞血酸及抗壞血酸之鹽所組成之群組中的至少一種、(B)丙二醇、(C)油分、及(D)聚矽氧系界面活性劑之油中水型外用組成物。 [Water-in-oil composition for external use] The water-in-oil type composition for external use of the present invention contains (A) at least one selected from the group consisting of ascorbic acid and ascorbic acid salts, (B) propylene glycol, (C) oil, and (D) polysiloxane Water-in-oil type external composition of surfactant.

[(A)選自由抗壞血酸及抗壞血酸之鹽所組成之群組中的至少一種] 作為本發明中所使用之抗壞血酸,可使用於醫藥品、準藥品或化妝品領域中作為皮膚外用劑之成分市售之抗壞血酸,這些通常係指L體之抗壞血酸。 [(A) At least one selected from the group consisting of ascorbic acid and a salt of ascorbic acid] Ascorbic acid used in the present invention can be used as ascorbic acid commercially available as a component of external skin preparations in the field of pharmaceuticals, quasi-drugs, or cosmetics, and these generally refer to L-form ascorbic acid.

於本發明中,亦可使用抗壞血酸之鹽。此處,抗壞血酸之鹽係指藥學上所容許之鹽。並無限定,例如可例舉:與有機鹼之鹽(例如,三甲胺鹽、三乙胺鹽、單乙醇胺鹽、三乙醇胺鹽、吡啶鹽等與三級胺之鹽、精胺酸等鹼性銨鹽等)、與無機鹼之鹽(例如,銨鹽、鈉鹽、鉀鹽等鹼金屬鹽、鈣鹽、鎂鹽等鹼土金屬鹽、鋁鹽等)等。尤佳的抗壞血酸之鹽為鈉鹽、鉀鹽。具體而言,可例舉:抗壞血酸鈉、抗壞血酸單磷酸酯鈉、抗壞血酸二磷酸酯鈉、抗壞血酸三磷酸酯鈉、抗壞血酸-2-硫酸酯鈉等。In the present invention, a salt of ascorbic acid can also be used. Here, the salt of ascorbic acid means a pharmaceutically acceptable salt. It is not limited, for example: salts with organic bases (for example, trimethylamine salts, triethylamine salts, monoethanolamine salts, triethanolamine salts, pyridinium salts, etc.) and tertiary amine salts, arginine and other basic ammonium salts, etc.), salts with inorganic bases (for example, alkali metal salts such as ammonium salts, sodium salts, and potassium salts, alkaline earth metal salts such as calcium salts, and magnesium salts, aluminum salts, etc.), and the like. Preferred salts of ascorbic acid are sodium salt and potassium salt. Specifically, sodium ascorbate, sodium ascorbyl monophosphate, sodium ascorbyl diphosphate, sodium ascorbyl triphosphate, sodium ascorbyl-2-sulfate, and the like may, for example, be mentioned.

於本發明中,抗壞血酸或其鹽可使用一種或組合使用兩種以上。In the present invention, ascorbic acid or a salt thereof may be used alone or in combination of two or more.

本發明之油中水型外用組成物中,相對於油中水型外用組成物的總量之(A)成分的總含量可根據與其他成分之平衡而適宜設定。相對於油中水型外用組成物的總量,(A)成分的總含量較佳為1質量%以上,更佳為3質量%以上,進而較佳為5質量%以上。相對於油中水型外用組成物的總量,(A)成分的總含量較佳為30質量%以下,更佳為20質量%以下,進而較佳為15質量%以下。相對於油中水型外用組成物的總量,(A)成分的總含量較佳為1質量%至30質量%,更佳為3質量%至20質量%,進而較佳為5質量%至15質量%,進而更佳為5質量%至10質量%。另外,亦可為1質量%至10質量%、2質量%至7質量%、3質量%至5質量%等。In the water-in-oil type external use composition of this invention, the total content of (A) component with respect to the total amount of the water-in-oil type external use composition can be set suitably according to the balance with other components. The total content of the component (A) is preferably at least 1% by mass, more preferably at least 3% by mass, and still more preferably at least 5% by mass, based on the total amount of the water-in-oil type external use composition. The total content of the (A) component is preferably at most 30% by mass, more preferably at most 20% by mass, further preferably at most 15% by mass, based on the total amount of the water-in-oil type external composition. The total content of the component (A) is preferably from 1% by mass to 30% by mass, more preferably from 3% by mass to 20% by mass, further preferably from 5% by mass to the total amount of the water-in-oil type external composition. 15% by mass, and more preferably 5% to 10% by mass. In addition, 1 mass % to 10 mass %, 2 mass % to 7 mass %, 3 mass % to 5 mass %, etc. may be sufficient.

[(B)丙二醇] 作為本發明中所使用之丙二醇,只要為於醫藥品、準藥品或化妝品領域中用作皮膚外用劑之成分之丙二醇,則並無特別限定。另外,可直接使用市售品。丙二醇係指1,3-丙二醇(CAS編號:504-63-2,英文名:1,3-Dihydroxypropane或TrimethyleneGlycol)。(B)成分可有助於本發明之油中水型外用組成物的穩定性。 [(B) Propylene Glycol] The propylene glycol used in the present invention is not particularly limited as long as it is used as a component of external skin preparations in the field of pharmaceuticals, quasi-drugs, or cosmetics. In addition, a commercially available product can be used as it is. Propylene glycol refers to 1,3-propanediol (CAS number: 504-63-2, English name: 1,3-Dihydroxypropane or Trimethylene Glycol). The component (B) contributes to the stability of the water-in-oil composition for external use of the present invention.

本發明之油中水型外用組成物中,相對於油中水型外用組成物的總量之(B)成分的總含量並無特別限定,較佳為15質量%以上,更佳為20質量%以上,進而較佳為30質量%以上,進而更佳為40質量%以上。相對於油中水型外用組成物的總量之(B)成分的總含量較佳為80質量%以下,更佳為70質量%以下,進而較佳為60質量%以下。就提高本發明之油中水型外用組成物的穩定性之觀點而言,相對於油中水型外用組成物的總量之(B)成分的總含量並無特別限定,較佳為15質量%至80質量%,更佳為20質量%至75質量%,進而較佳為40質量%至70質量%。另外,亦可為20質量%至80質量%、20質量%至60質量%、30質量%至75質量%、30質量%至60質量%、或40質量%至60質量%等範圍。In the water-in-oil type external use composition of the present invention, the total content of (B) component is not particularly limited relative to the total amount of the water-in-oil type external use composition, but is preferably 15% by mass or more, more preferably 20% by mass % or more, more preferably 30% by mass or more, and more preferably 40% by mass or more. The total content of the (B) component is preferably at most 80% by mass, more preferably at most 70% by mass, further preferably at most 60% by mass, based on the total amount of the water-in-oil type external use composition. From the viewpoint of improving the stability of the water-in-oil composition for external use of the present invention, the total content of component (B) relative to the total amount of the water-in-oil composition for external use is not particularly limited, but is preferably 15 mass % to 80 mass%, more preferably 20 mass% to 75 mass%, and more preferably 40 mass% to 70 mass%. In addition, it may be in the range of 20 mass % to 80 mass %, 20 mass % to 60 mass %, 30 mass % to 75 mass %, 30 mass % to 60 mass %, or 40 mass % to 60 mass %.

本發明之油中水型外用組成物中,相對於(A)成分之(B)成分的調配量的比率並無特別限定,相對於(A)成分的總含量1質量份,較佳為0.5質量份至80質量份,更佳為1質量份至30質量份,進而較佳為4質量份至12質量份。另外,亦可為2質量份至80質量份、4質量份至35質量份、8質量份至20質量份等。In the water-in-oil type composition for external use of the present invention, the ratio of the compounded amount of (B) component to (A) component is not particularly limited, but is preferably 0.5 per part by mass of the total content of (A) component Parts by mass to 80 parts by mass, more preferably 1 part by mass to 30 parts by mass, further preferably 4 parts by mass to 12 parts by mass. Moreover, 2 mass parts - 80 mass parts, 4 mass parts - 35 mass parts, 8 mass parts - 20 mass parts, etc. may be sufficient.

[(C)油分] 作為本發明中所使用之(C)油分,並無限定,例如可例舉:天然動植物油脂類、烴油、酯油、聚矽氧油、高級脂肪酸、動植物、合成之精油等。 [(C) oil content] The (C) oil used in the present invention is not limited, and examples thereof include natural animal and vegetable oils, hydrocarbon oils, ester oils, silicone oils, higher fatty acids, animals and plants, and synthetic essential oils.

作為天然動植物油脂類,例如可例舉:鱷梨油、亞麻籽油、杏仁油、橄欖油、可可油、牛油、桐油、小麥胚芽油、芝麻油、米胚芽油、米糠油、紅花油、大豆油、月見草油、山茶油、玉米油、菜籽油、馬油、桃仁油、棕櫚油、棕櫚仁油、蓖麻油、葵花籽油、豬油、葡萄油、荷荷芭油、澳洲胡桃油、貂油、棉籽油、木蠟、蜂蠟、白蜂蠟、椰子油、氫化油(非限定性的示例為氫化荷荷芭油、氫化蓖麻油、氫化大豆油、氫化米油、氫化椰子油等)、花生油、羊毛脂、蛋黃油、玫瑰果油、薄荷油、檸檬油、桉葉油、薰衣草油、羅馬洋甘菊油、柳橙油、薏苡油、西番蓮籽油(Passiflora Edulis Seed Oil)、野薔薇油、茶樹油、葡萄柚油、雜薰衣草油、岩薔薇油、茴香油、或橙皮油(Orange Roughy Oil)等。Examples of natural animal and vegetable oils include avocado oil, linseed oil, almond oil, olive oil, cocoa butter, butter, tung oil, wheat germ oil, sesame oil, rice germ oil, rice bran oil, safflower oil, Soybean Oil, Evening Primrose Oil, Camellia Oil, Corn Oil, Rapeseed Oil, Horse Oil, Peach Kernel Oil, Palm Oil, Palm Kernel Oil, Castor Oil, Sunflower Oil, Lard Oil, Grape Oil, Jojoba Oil, Macadamia Oil, Mink oil, cottonseed oil, wood wax, beeswax, white beeswax, coconut oil, hydrogenated oils (non-limiting examples are hydrogenated jojoba oil, hydrogenated castor oil, hydrogenated soybean oil, hydrogenated rice oil, hydrogenated coconut oil, etc.), Peanut Oil, Lanolin, Egg Butter, Rosehip Oil, Peppermint Oil, Lemon Oil, Eucalyptus Oil, Lavender Oil, Roman Chamomile Oil, Orange Oil, Coix Oil, Passiflora Edulis Seed Oil, Rosa Rosa Oil , tea tree oil, grapefruit oil, miscellaneous lavender oil, cistus oil, fennel oil, or orange peel oil (Orange Roughy Oil).

作為烴油,例如可使用石蠟系烴、烯烴系烴,更具體而言,例如可例舉:角鯊烷、角鯊烯、地蠟(ceresin)、石蠟、姥鮫烷、微晶蠟、液態石蠟、凡士林、烯烴寡聚物、氫化聚異丁烯、異構石蠟、聚乙烯蠟、地石蠟(ozokerite)等。As the hydrocarbon oil, for example, paraffinic hydrocarbons and olefinic hydrocarbons can be used, and more specifically, for example, squalane, squalene, ceresin, paraffin, pristane, microcrystalline wax, liquid Paraffin wax, vaseline, olefin oligomer, hydrogenated polyisobutylene, isoparaffin, polyethylene wax, ozokerite, etc.

作為酯油,例如可使用合成酯類、高級醇與高級脂肪酸之酯類,例如可例舉:己二酸二異丁酯、己二酸2-己基癸酯、己二酸二-2-庚基十一烷基酯、異硬脂酸異硬脂酯、三羥甲基丙烷三異硬脂酸酯、2-乙基己酸鯨蠟酯、新戊二醇二-2-乙基己酸酯、三羥甲基丙烷三-2-乙基己酸酯、季戊四醇四-2-乙基己酸酯、辛酸鯨蠟酯、油酸油酯、油酸辛基十二烷基酯、油酸癸酯、新戊二醇二癸酸酯、琥珀酸2-乙基己酯、硬脂酸異鯨蠟酯、硬脂酸丁酯、癸二酸二異丙酯、乳酸鯨蠟酯、乳酸十四烷基酯、肉豆蔻酸異丙酯、肉豆蔻酸辛基十二烷基酯、肉豆蔻酸鯨蠟酯、肉豆蔻酸肉豆蔻酯、棕櫚酸辛酯、棕櫚酸2-乙基己酯、棕櫚酸2-己基癸酯、棕櫚酸2-庚基十一烷基酯、膽固醇12-羥基硬脂酸酯、植固醇油酸酯、蘋果酸二異硬脂酯、對甲氧基肉桂酸酯、季戊四醇四松脂酸酯、或甘油三(辛酸/癸酸)酯等。As the ester oil, for example, synthetic esters, esters of higher alcohols and higher fatty acids can be used, for example, diisobutyl adipate, 2-hexyldecyl adipate, di-2-heptyl adipate Undecyl Isostearate, Isostearyl Isostearate, Trimethylolpropane Triisostearate, Cetyl 2-Ethylhexanoate, Neopentyl Glycol Di-2-Ethylhexanoate Esters, trimethylolpropane tri-2-ethylhexanoate, pentaerythritol tetra-2-ethylhexanoate, cetyl caprylate, oleyl oleate, octyldodecyl oleate, decyl oleate Esters, Neopentyl Glycol Dicaprate, 2-Ethylhexyl Succinate, Isocetyl Stearate, Butyl Stearate, Diisopropyl Sebacate, Cetyl Lactate, Myristyl Lactate Alkyl esters, Isopropyl myristate, Octyldodecyl myristate, Cetyl myristate, Myristyl myristate, Octyl palmitate, 2-Ethylhexyl palmitate, Palmitic acid 2-Hexyldecyl Ester, 2-Heptyl Undecyl Palmitate, Cholesterol 12-Hydroxystearate, Phytosteryl Oleate, Diisostearyl Malate, P-Methoxycinnamate, Pentaerythritol tetrarosinate, or triglyceride (caprylic acid/capric acid) ester, etc.

所謂聚矽氧油,典型地指包含至少1個矽原子、尤其是包含至少1個Si-O基之油。亦可使用具有2個至7個之矽原子,且任意地包含含有1個至10個碳原子之烷基或烷氧基之油。作為聚矽氧油,例如可例舉:二甲基聚矽氧烷、甲基聚矽氧烷(包含高聚合甲基聚矽氧烷、交聯型甲基聚矽氧烷)、甲基苯基聚矽氧烷、甲基氫聚矽氧烷、環六矽氧烷、八甲基環四矽氧烷、八甲基環五矽氧烷、十甲基環六矽氧烷、辛基甲聚矽氧烷、十甲基環五矽氧烷、十二甲基環六矽氧烷、七甲基己基三矽氧烷、七甲基辛基三矽氧烷、六甲基二矽氧烷、八甲基三矽氧烷、十甲基四矽氧烷及十二甲基五矽氧烷、硬脂氧基聚矽氧等高級烷氧基改質聚矽氧、烷基改質聚矽氧、高級脂肪酸酯改質聚矽氧等或這些之混合物。The so-called polysiloxane oil typically refers to an oil containing at least one silicon atom, especially at least one Si-O group. Oils having 2 to 7 silicon atoms, optionally containing alkyl or alkoxy groups containing 1 to 10 carbon atoms, may also be used. Examples of silicone oils include: dimethylpolysiloxane, methylpolysiloxane (including high-polymerization methylpolysiloxane, cross-linked methylpolysiloxane), methylbenzene Polysiloxane, Methylhydropolysiloxane, Cyclohexasiloxane, Octamethylcyclotetrasiloxane, Octamethylcyclopentasiloxane, Decamethylcyclohexasiloxane, Octylmethyl Polysiloxane, Decamethylcyclopentasiloxane, Dodecamethylcyclohexasiloxane, Heptamethylhexyltrisiloxane, Heptamethyloctyltrisiloxane, Hexamethyldisiloxane , octamethyltrisiloxane, decamethyltetrasiloxane and dodecamethylpentasiloxane, stearoxy polysiloxane and other advanced alkoxy modified polysiloxane, alkyl modified polysiloxane Oxygen, higher fatty acid ester modified polysiloxane, etc. or a mixture of these.

作為高級脂肪酸,可使用飽和或不飽和之直鏈或支鏈之碳數12至22之脂肪酸,例如可例舉:異硬脂酸、氧硬脂酸、油酸、硬脂酸、棕櫚酸、俞樹酸、肉豆蔻酸、月桂酸、羊毛脂酸、亞麻油酸、次亞麻油酸等。As higher fatty acids, saturated or unsaturated linear or branched fatty acids with 12 to 22 carbon atoms can be used, for example, isostearic acid, oxystearic acid, oleic acid, stearic acid, palmitic acid, Yushu acid, myristic acid, lauric acid, lanolic acid, linoleic acid, sublinolenic acid, etc.

作為(C)成分,可使用這些成分中的一種或組合使用兩種以上。 並無限定,作為(C)成分,較佳為至少包含聚矽氧油。 As (C)component, these components can be used 1 type or in combination of 2 or more types. It is not limited, but as (C)component, it is preferable to contain silicone oil at least.

這些油分可利用天然物或藉由合成而製備,亦可直接使用市售品。These oils can be prepared using natural products or by synthesis, and commercial products can also be used as they are.

本發明之油中水型外用組成物中,相當於油中水型外用組成物的總量之(C)成分的總含量並無特別限定,較佳為1質量%以上,更佳為3質量%以上,進而較佳為5質量%以上。相對於油中水型外用組成物的總量,(C)成分的總含量較佳為40質量%以下,更佳為30質量%以下,進而較佳為20質量%以下。相對於油中水型外用組成物的總量,(C)成分的含量較佳為1質量%至40質量%,更佳為3質量%至30質量%,進而較佳為5質量%至20質量%。In the water-in-oil type external use composition of the present invention, the total content of (C) component equivalent to the total amount of the water-in-oil type external use composition is not particularly limited, but is preferably at least 1% by mass, more preferably 3% by mass % or more, and more preferably 5% by mass or more. The total content of the component (C) is preferably at most 40% by mass, more preferably at most 30% by mass, further preferably at most 20% by mass, based on the total amount of the water-in-oil type external use composition. The content of component (C) is preferably from 1% by mass to 40% by mass, more preferably from 3% by mass to 30% by mass, further preferably from 5% by mass to 20% by mass, based on the total amount of the water-in-oil type external composition. quality%.

本發明之油中水型外用組成物中,相對於(A)成分之(C)成分的調配量的比率並無特別限定,相對於(A)成分的總含量1質量份,較佳為0.01質量份至40質量份,更佳為0.1質量份至10質量份,進而較佳為0.5質量份至4質量份。另外,亦可為0.1質量份至40質量份、0.4質量份至15質量份、1質量份至7質量份等。In the water-in-oil type external composition of the present invention, the ratio of the compounded amount of (C) component to (A) component is not particularly limited, but is preferably 0.01 per part by mass of the total content of (A) component Parts by mass to 40 parts by mass, more preferably 0.1 parts by mass to 10 parts by mass, further preferably 0.5 parts by mass to 4 parts by mass. In addition, 0.1 to 40 parts by mass, 0.4 to 15 parts by mass, 1 to 7 parts by mass, etc. may be used.

[(D)聚矽氧系界面活性劑] 本發明中所使用之(D)聚矽氧系界面活性劑並無限定,就提高本發明之油中水型外用組成物的穩定性之觀點而言,例如可例舉:(二甲聚矽氧烷/(PEG-10/15))交聯聚合物、PEG-11甲醚二甲聚矽氧烷、PEG/PPG-20/22丁醚二甲聚矽氧烷、PEG-3二甲聚矽氧烷、PEG-10二甲聚矽氧烷、PEG-32甲醚二甲聚矽氧烷、鯨蠟基PEG/PPG-10/1二甲聚矽氧烷、PEG-9聚二甲基矽烷氧基乙基二甲聚矽氧烷、月桂基PEG-9聚二甲基矽烷氧基乙基二甲聚矽氧烷、鯨蠟基二甘油基三(三甲基矽烷氧基)矽基乙基二甲聚矽氧烷、或聚氧乙烯-甲基聚矽氧烷共聚物等。較佳的活性劑的HLB(Hydrophilic Lipophilic Balance,親水親油平衡值)較佳為1至10,更佳為2至8,更佳為3至5。 [(D) Polysiloxane Surfactant] The (D) polysiloxane-based surfactant used in the present invention is not limited, and from the viewpoint of improving the stability of the oil-in-water type composition for external use of the present invention, for example: (Dimethicone Oxane/(PEG-10/15)) Crosspolymer, PEG-11 Methyl Ether Dimethicone, PEG/PPG-20/22 Butyl Ether Dimethicone, PEG-3 Dimethicone Silicone, PEG-10 Dimethicone, PEG-32 Methyl Ether Dimethicone, Cetyl PEG/PPG-10/1 Dimethicone, PEG-9 Dimethicone Siloxyethyl Dimethicone, Lauryl PEG-9 Polydimethylsiloxyethyl Dimethicone, Cetyl Diglyceryl Tris(trimethylsiloxy)silyl Ethyl dimethyl polysiloxane, or polyoxyethylene-methyl polysiloxane copolymer, etc. The HLB (Hydrophilic Lipophilic Balance) of the preferred active agent is preferably 1-10, more preferably 2-8, and more preferably 3-5.

作為(D)成分,可使用這些成分中的一種或組合使用兩種以上。As (D)component, these components can be used 1 type or in combination of 2 or more types.

本發明之油中水型外用組成物中,相對於油中水型外用組成物的總量之(D)成分的總含量並無特別限定,就提高本發明之油中水型外用組成物的穩定性之觀點而言,較佳為1質量%以上,更佳為3質量%以上,進而較佳為5質量%以上。相對於油中水型外用組成物的總量,(D)成分的總含量較佳為30質量%以下,更佳為20質量%以下,進而較佳為10質量%以下。(D)成分的總含量較佳為1質量%至30質量%,更佳為,3質量%至20質量%,進而較佳為5質量%至10質量%。In the water-in-oil composition for external use of the present invention, the total content of component (D) relative to the total amount of the water-in-oil composition for external use is not particularly limited. From the viewpoint of stability, it is preferably at least 1% by mass, more preferably at least 3% by mass, and still more preferably at least 5% by mass. The total content of the component (D) is preferably at most 30% by mass, more preferably at most 20% by mass, and still more preferably at most 10% by mass, based on the total amount of the water-in-oil type external use composition. The total content of (D) components is preferably from 1% by mass to 30% by mass, more preferably from 3% by mass to 20% by mass, further preferably from 5% by mass to 10% by mass.

本發明之油中水型外用組成物中,相對於(A)成分之(D)成分的比率相對於(A)成分的總含量1質量份,較佳為0.01質量份至30質量份,更佳為0.1質量份至7質量份,進而較佳為0.5質量份至2質量份。另外,亦可為0.1質量份至30質量份、0.4質量份至10質量份、1質量份至4質量份等。In the water-in-oil type composition for external use of the present invention, the ratio of component (D) to component (A) is preferably 0.01 to 30 parts by mass, more preferably 0.01 to 30 parts by mass, based on 1 part by mass of the total content of component (A). Preferably, it is 0.1 mass part - 7 mass parts, More preferably, it is 0.5 mass part - 2 mass parts. In addition, 0.1 to 30 parts by mass, 0.4 to 10 parts by mass, 1 to 4 parts by mass, etc. may be used.

[水] 本發明之油中水型外用組成物可為含有水之液狀組成物,亦可為不含水之組成物。所調配之水的比例並無限定,相對於油中水型外用組成物,較佳為15質量%以下,更佳為10質量%以下,進而較佳為7質量%以下。於含有水之情形時,較佳為1質量%至15質量%,更佳為1質量%至10質量%,進而較佳為1質量%至7質量%。即便於本發明之油中水型外用組成物中不含水之情形時,藉由(B)成分或任意之水性成分,亦會形成油中水型中的水相。 [water] The water-in-oil composition for external use of the present invention may be a liquid composition containing water, or a composition containing no water. The ratio of the water to be formulated is not limited, but is preferably at most 15% by mass, more preferably at most 10% by mass, and still more preferably at most 7% by mass, relative to the water-in-oil type external use composition. When water is contained, it is preferably 1% by mass to 15% by mass, more preferably 1% by mass to 10% by mass, further preferably 1% by mass to 7% by mass. Even when the water-in-oil type external composition of the present invention does not contain water, the water phase in the water-in-oil type is formed by the component (B) or any aqueous component.

本發明之油中水型外用組成物中,關於相對於(A)成分之水的比率,相對於(A)成分的總含量1質量份,較佳為0.01質量份至10質量份,更佳為0.05質量份至3質量份,進而較佳為0.1質量份至1質量份。另外,亦可為0.1質量份至10質量份、0.1質量份至3.5質量份、0.2質量份至2質量份等。In the water-in-oil type external composition of the present invention, the ratio of water to component (A) is preferably 0.01 to 10 parts by mass, more preferably 0.01 to 10 parts by mass, based on 1 part by mass of the total content of component (A) 0.05 to 3 parts by mass, and more preferably 0.1 to 1 part by mass. Moreover, 0.1-10 mass parts, 0.1-3.5 mass parts, 0.2-2 mass parts, etc. may be sufficient.

[(E)低級醇] 本發明之油中水型外用組成物中,就使用感之提升、更高的穩定性及經皮吸收之促進之觀點而言,只要不妨礙本發明的效果,則除上述(A)成分、(B)成分、(C)成分及(D)成分以外,亦可任意地包含(E)低級醇。 作為本發明中所使用之低級醇,只要為於醫藥品、準藥品或化妝品領域中用作皮膚外用劑之成分之低級醇,則並無特別限定。本說明書中,記為「低級醇」時,係指C1-C6之醇。當中,可尤佳地使用C1-C3之醇。作為此種示例,可例舉:甲醇、乙醇、正丙醇、異丙醇等。 [(E) lower alcohol] In the water-in-oil type composition for external use of the present invention, from the viewpoint of improvement of the feeling of use, higher stability, and promotion of percutaneous absorption, as long as the effect of the present invention is not hindered, in addition to the above-mentioned (A) component, In addition to (B) component, (C) component, and (D) component, (E) lower alcohol may be included arbitrarily. The lower alcohol used in the present invention is not particularly limited as long as it is used as a component of external skin preparations in the field of pharmaceuticals, quasi-drugs, or cosmetics. In this specification, when described as "lower alcohol", it means C1-C6 alcohol. Among them, C1-C3 alcohols can be particularly preferably used. As such an example, methanol, ethanol, n-propanol, isopropanol, etc. are mentioned.

於本發明之一態樣中,相對於油中水型外用組成物的總量之(E)成分的總含量較佳為1質量%至30質量%,更佳為3質量%至20質量%,進而較佳為5質量%至10質量%。In one aspect of the present invention, the total content of the (E) component is preferably 1% by mass to 30% by mass, more preferably 3% by mass to 20% by mass relative to the total amount of the water-in-oil type external composition , and more preferably 5% by mass to 10% by mass.

本發明之油中水型外用組成物中,關於相對於(A)成分之(E)成分的調配量的比率,相對於(A)成分的總含量1質量份,較佳為0.01質量份至30質量份,更佳為0.1質量份至7質量份,進而較佳為0.5質量份至2質量份。另外,亦可為0.1質量份至30質量份、0.2質量份至15質量份、0.4質量份至10質量份、1質量份至4質量份等。In the water-in-oil type external composition of the present invention, the ratio of the compounded amount of (E) component to (A) component is preferably 0.01 mass part to 1 mass part of the total content of (A) component 30 parts by mass, more preferably 0.1 to 7 parts by mass, further preferably 0.5 to 2 parts by mass. In addition, 0.1 to 30 parts by mass, 0.2 to 15 parts by mass, 0.4 to 10 parts by mass, 1 to 4 parts by mass, etc. may be used.

[多元醇] 本發明之油中水型外用組成物中,只要不妨礙本發明的效果,則除上述(A)成分、(B)成分、(C)成分及(D)成分以外,亦可包含(B)成分以外的多元醇。 [Polyol] In the water-in-oil type external composition of the present invention, as long as the effects of the present invention are not hindered, in addition to the above-mentioned (A) component, (B) component, (C) component, and (D) component, (B) component may also be included. Polyols other than ingredients.

作為本發明中所使用之多元醇,只要為於醫藥品、準藥品或化妝品領域中用作皮膚外用劑之成分之多元醇,則並無特別限定。多元醇並無限定,有時亦為了保濕或作為助溶劑而添加。具體而言,可例舉:甘油、雙甘油、二丙二醇、丙二醇、1,3-丁二醇、3-甲基-1,3-丁二醇、己二醇、戊二醇、山梨醇、或麥芽糖醇等。The polyol used in the present invention is not particularly limited as long as it is used as a component of external skin preparations in the field of pharmaceuticals, quasi-drugs, or cosmetics. The polyhydric alcohol is not limited, and may be added for moisturizing or as a solubilizing agent. Specifically, glycerin, diglycerin, dipropylene glycol, propylene glycol, 1,3-butanediol, 3-methyl-1,3-butanediol, hexanediol, pentylene glycol, sorbitol, or maltitol etc.

於本發明之一態樣中,於含有(B)成分以外的多元醇之情形時,相對於油中水型外用組成物的總量,(B)成分以外的多元醇的總含量較佳為0.1質量%至30質量%,更佳為0.5質量%至20質量%,進而較佳為1質量%至10質量%左右。In one aspect of the present invention, when polyhydric alcohols other than component (B) are contained, the total content of polyhydric alcohols other than component (B) is preferably 0.1% by mass to 30% by mass, more preferably 0.5% by mass to 20% by mass, further preferably about 1% by mass to 10% by mass.

於本發明之一態樣中,(B)成分於油中水型外用組成物中的多元醇整體中所佔之較佳比例可為30%質量以上,更佳可為40質量%以上。於本發明之一態樣中,亦可為僅包含(B)成分作為油中水型外用組成物中的多元醇之態樣。In one aspect of the present invention, the ratio of component (B) to the total polyol in the water-in-oil type composition for external use is preferably 30% by mass or more, more preferably 40% by mass or more. In one aspect of this invention, the aspect which contains only (B) component as a polyhydric alcohol in a water-in-oil type composition for external use may be sufficient.

於本發明之一態樣中,關於相對於(B)成分之(B)成分以外的多元醇的比率,就提高穩定性之觀點而言,相對於(B)成分的含量1質量份,較佳為0質量份至3質量份,更佳為0.001質量份至2質量份,進而較佳為0.005質量份至1.5質量份。另外,相對於(B)成分的含量1質量份,(B)成分以外的多元醇的比率亦可為0質量份至1質量份、0質量份至0.5質量份、0質量份至0.35質量份等。In one aspect of the present invention, the ratio of the polyhydric alcohols other than the (B) component to the (B) component is relatively low relative to 1 part by mass of the content of the (B) component from the viewpoint of improving stability. Preferably, it is 0 mass part - 3 mass parts, More preferably, it is 0.001 mass part - 2 mass parts, More preferably, it is 0.005 mass part - 1.5 mass parts. In addition, the ratio of polyhydric alcohols other than component (B) may be 0 to 1 part by mass, 0 to 0.5 parts by mass, or 0 to 0.35 parts by mass with respect to 1 part by mass of the content of component (B). wait.

於本發明之一態樣中,就提高穩定性之觀點而言,例如相對於(B)成分的含量1質量份,1,3-丁二醇較佳可為0質量份至3質量份,更佳可為0.001質量份至2質量份,進而較佳可為0.005質量份至1質量份。In one aspect of the present invention, from the viewpoint of improving stability, for example, 1,3-butanediol is preferably 0 to 3 parts by mass relative to 1 part by mass of the content of component (B), More preferably, it may be 0.001 to 2 parts by mass, and still more preferably, it may be 0.005 to 1 part by mass.

[3-O-乙基抗壞血酸] 本發明之油中水型外用組成物中,只要不妨礙本發明的效果,則除上述(A)成分、(B)成分、(C)成分及(D)成分以外,亦可包含3-O-乙基抗壞血酸或其鹽。 3-O-乙基抗壞血酸可將抗壞血酸的3位上的羥基進行乙氧基化而合成(例如,依據日本特開平8-134055中所記載之公知的方法等)。3-O-乙基抗壞血酸亦可直接使用市售品。作為市售品,並無限定,例如,除日本精化製造的「VC乙醚」以外,亦例示有純正化學股份有限公司製造的製品等。 [3-O-Ethyl Ascorbic Acid] In the water-in-oil type external composition of the present invention, as long as the effect of the present invention is not hindered, in addition to the above-mentioned (A) component, (B) component, (C) component and (D) component, 3-O - Ethyl ascorbic acid or a salt thereof. 3-O-Ethyl ascorbic acid can be synthesized by ethoxylating the hydroxyl group at the 3-position of ascorbic acid (for example, according to a known method described in JP-A-8-134055). 3-O-Ethyl ascorbic acid can also use a commercial item as it is. The commercially available product is not limited, and for example, "VC diethyl ether" manufactured by Nippon Seika Co., Ltd., and products manufactured by Junsei Chemical Co., Ltd. are also illustrated.

3-O-乙基抗壞血酸有助於本發明之油中水型外用組成物的穩定性。3-O-ethyl ascorbic acid contributes to the stability of the water-in-oil topical composition of the present invention.

3-O-乙基抗壞血酸亦可以鹽的形式使用。此處,3-O-乙基抗壞血酸之鹽係指藥學上所容許之鹽。並無限定,例如可例舉:與有機鹼之鹽(例如,三甲胺鹽、三乙胺鹽、單乙醇胺鹽、三乙醇胺鹽、吡啶鹽等與三級胺之鹽、精胺酸等鹼性銨鹽等)、與無機鹼之鹽(例如,銨鹽、鈉鹽、鉀鹽等鹼金屬鹽、鈣鹽、鎂鹽等鹼土金屬鹽、鋁鹽等)等。尤佳的3-O-乙基抗壞血酸之鹽為鈉鹽、鉀鹽。3-O-Ethyl ascorbic acid can also be used in the form of a salt. Here, the salt of 3-O-ethyl ascorbic acid refers to a pharmaceutically acceptable salt. It is not limited, for example: salts with organic bases (for example, trimethylamine salts, triethylamine salts, monoethanolamine salts, triethanolamine salts, pyridinium salts, etc.) and tertiary amine salts, arginine and other basic ammonium salts, etc.), salts with inorganic bases (for example, alkali metal salts such as ammonium salts, sodium salts, and potassium salts, alkaline earth metal salts such as calcium salts, and magnesium salts, aluminum salts, etc.), and the like. Particularly preferred salts of 3-O-ethyl ascorbic acid are sodium salts and potassium salts.

於本發明中,3-O-乙基抗壞血酸或其鹽可使用一種或組合使用兩種以上。In the present invention, 3-O-ethylascorbic acid or a salt thereof may be used alone or in combination of two or more.

於本發明之一態樣中,相對於油中水型外用組成物的總量之3-O-乙基抗壞血酸或其鹽的總含量可根據與其他成分之平衡而適宜設定。相對於油中水型外用組成物的總量,3-O-乙基抗壞血酸或其鹽的總含量較佳為0.0001質量%至10質量%,更佳為0.001質量%至5質量%,進而較佳為0.005質量%至3質量%,進而更佳為0.01質量%至3質量%。In one aspect of the present invention, the total content of 3-O-ethyl ascorbic acid or its salt relative to the total amount of the water-in-oil composition for external use can be appropriately set based on the balance with other components. The total content of 3-O-ethyl ascorbic acid or its salt is preferably from 0.0001% by mass to 10% by mass, more preferably from 0.001% by mass to 5% by mass, relative to the total amount of the water-in-oil type external composition, and further preferably Preferably, it is 0.005 mass % to 3 mass %, More preferably, it is 0.01 mass % to 3 mass %.

於本發明之一態樣中,關於相對於(A)成分之3-O-乙基抗壞血酸或其鹽的調配量的比率,相對於(A)成分的總含量1質量份,3-O-乙基抗壞血酸或其鹽的總含量較佳為0.000003質量份至10質量份,更佳為0.00025質量份至1質量份,進而較佳為0.001質量份至0.6質量份。In one aspect of the present invention, regarding the ratio of the compounded amount of 3-O-ethyl ascorbic acid or its salt to (A) component, 3-O- The total content of ethyl ascorbic acid or its salts is preferably 0.000003 to 10 parts by mass, more preferably 0.00025 to 1 part by mass, further preferably 0.001 to 0.6 parts by mass.

[(D)成分以外的界面活性劑] 只要不妨礙本發明的效果,則本發明之油中水型外用組成物亦可包含界面活性劑。界面活性劑可有助於成分的穩定化。作為界面活性劑,例如可使用聚氧乙烯氫化蓖麻油40、聚氧乙烯氫化蓖麻油60、聚氧乙烯氫化蓖麻油80、聚氧乙烯聚氧丙烯癸基十四烷基醚、聚氧乙烯(20)聚氧丙烯(4)鯨蠟醚、PEG-8甘油異硬脂酸酯、聚氧乙烯山梨醇酐單月桂酸酯(20E.O.)、聚氧乙烯山梨醇酐異硬脂酸酯(20E.O.)、聚氧乙烯山梨醇酐硬脂酸酯(20E.O.)、聚甘油-10椰子油脂肪酸酯、聚甘油-3椰子油脂肪酸酯、PEG-7甘油椰子油脂肪酸酯、聚甘油-10二油酸酯、聚甘油-10二異硬脂酸酯、PEG-40甘油三異硬脂酸酯、PEG-40甘油異硬脂酸酯、聚甘油-10三月桂酸酯、六甘油三辛酸酯、聚甘油月桂酸酯、聚甘油肉豆蔻酸酯、聚氧乙烯月桂醚等,尤其可例舉:聚氧乙烯聚氧丙烯癸基十四烷基醚、聚氧乙烯氫化蓖麻油40、聚氧乙烯氫化蓖麻油60、聚氧乙烯氫化蓖麻油80、聚氧乙烯山梨醇酐異硬脂酸酯(20E.O.)、聚氧乙烯山梨醇酐單月桂酸酯(20E.O.)、聚甘油月桂酸酯等。 [Surfactant other than (D) component] The water-in-oil type external composition of the present invention may contain a surfactant as long as the effects of the present invention are not hindered. Surfactants can aid in the stabilization of ingredients. As the surfactant, for example, polyoxyethylene hydrogenated castor oil 40, polyoxyethylene hydrogenated castor oil 60, polyoxyethylene hydrogenated castor oil 80, polyoxyethylene polyoxypropylene decyl tetradecyl ether, polyoxyethylene ( 20) Polyoxypropylene (4) cetyl ether, PEG-8 glyceryl isostearate, polyoxyethylene sorbitan monolaurate (20E.O.), polyoxyethylene sorbitan isostearate (20E.O.), Polyoxyethylene Sorbitan Stearate (20E.O.), Polyglyceryl-10 Coconut Fatty Acid Ester, Polyglyceryl-3 Coconut Fatty Acid Ester, PEG-7 Glyceryl Coconut Oil Fatty acid ester, polyglyceryl-10 dioleate, polyglyceryl-10 diisostearate, PEG-40 glyceryl triisostearate, PEG-40 glyceryl isostearate, polyglyceryl-10 triisostearate Laurate, hexaglyceryl tricaprylate, polyglyceryl laurate, polyglyceryl myristate, polyoxyethylene lauryl ether, etc., especially, polyoxyethylene polyoxypropylene decyl tetradecyl ether, Polyoxyethylene hydrogenated castor oil 40, polyoxyethylene hydrogenated castor oil 60, polyoxyethylene hydrogenated castor oil 80, polyoxyethylene sorbitan isostearate (20E.O.), polyoxyethylene sorbitan monolauric Ester (20E.O.), polyglyceryl laurate, etc.

於本發明之一態樣中,相對於油中水型外用組成物的總量之界面活性劑的總含量可根據與其他成分之平衡而適宜設定。相對於油中水型外用組成物的總量,包括(D)成分在內之界面活性劑的總含量較佳為1質量%至30質量%,更佳為3質量%至20質量%,進而較佳為5質量%至10質量%。In one aspect of the present invention, the total content of the surfactant with respect to the total amount of the water-in-oil composition for external use can be appropriately set according to the balance with other components. The total content of the surfactant including component (D) is preferably from 1% by mass to 30% by mass, more preferably from 3% by mass to 20% by mass, based on the total amount of the water-in-oil type external composition, and further Preferably it is 5 mass % to 10 mass %.

[其他成分] 本發明之油中水型外用組成物中,除上述(A)成分、(B)成分、(C)成分及(D)成分以外,進而以增強或補充抗壞血酸以及或是其鹽所具有之各種作用為目的,且為了附加其他有用的作用,可將以下成分使用一種或組合使用兩種以上:美白成分、抗炎成分、抗菌成分、細胞活化成分、收斂成分、抗氧化成分、青春痘改善成分、膠原蛋白等活體成分合成促進成分、血流促進成分、保濕成分、抗老化成分等各種成分。較佳為美白成分、抗炎成分、抗菌成分、細胞活化成分、收斂成分、抗氧化成分、抗老化成分或保濕成分之一種或兩種以上之成分。作為這些成分的尤佳組合,可例舉:與美白成分之組合、美白成分與抗氧化成分之組合、與抗氧化成分之各組合、與抗老化成分之組合、美白成分與抗老化成分之各組合。作為這些各成分,只要為於醫藥品、準藥品、或化妝品領域中先前用作且將來用作皮膚外用劑之成分的成分,則並無特別限制,可適宜選擇使用任意成分。 [other ingredients] In the water-in-oil type external composition of the present invention, in addition to the above-mentioned (A) component, (B) component, (C) component, and (D) component, the various components of ascorbic acid and or its salts are further enhanced or supplemented. For the purpose of action, and in order to add other useful effects, the following ingredients can be used alone or in combination of two or more: whitening ingredients, anti-inflammatory ingredients, antibacterial ingredients, cell activation ingredients, astringent ingredients, antioxidant ingredients, acne improvement ingredients , Collagen and other biological ingredients synthesis promoting ingredients, blood flow promoting ingredients, moisturizing ingredients, anti-aging ingredients and other ingredients. Preferably, it is one or more of whitening ingredients, anti-inflammatory ingredients, antibacterial ingredients, cell activation ingredients, astringent ingredients, antioxidant ingredients, anti-aging ingredients or moisturizing ingredients. Examples of a particularly preferable combination of these ingredients include: a combination with a whitening ingredient, a combination of a whitening ingredient and an antioxidant ingredient, a combination with an antioxidant ingredient, a combination with an antiaging ingredient, and each of a whitening ingredient and an antiaging ingredient. combination. These components are not particularly limited as long as they are previously used in the field of pharmaceuticals, quasi-drugs, or cosmetics and will be used as components of external skin preparations in the future, and arbitrary components can be selected and used as appropriate.

[基劑或載體] 本發明之油中水型外用組成物中,就使用感之提升、穩定性之提升等觀點而言,只要不妨礙本發明的效果,則除上述(A)成分、(B)成分、及(C)成分以外,亦可包含基劑或載體。作為基劑或載體,例如可例舉:如乙基纖維素、羥基丙基纖維素、及羥基丙基甲基纖維素之類的纖維素衍生物;聚乙烯基吡咯烷酮;角叉菜膠;聚乙烯醇縮丁醛;聚乙二醇;如乙二醇單甲醚、乙二醇單乙醚、乙二醇單丙醚、二乙二醇單甲醚、二乙二醇單乙醚、二乙二醇單丙醚、二乙二醇單丁醚、丙二醇單乙醚、丙二醇單丙醚、二丙二醇單乙醚、及二丙二醇單丙醚之類的二醇醚;或二甲基二硬脂基銨鋰膨潤石等有機改質黏土礦物。基劑或載體可使用一種或兩種以上。 [base or carrier] In the water-in-oil type composition for external use of the present invention, in terms of the improvement of the feeling of use and the improvement of stability, as long as the effects of the present invention are not hindered, except for the above-mentioned (A) component, (B) component, and ( In addition to the component C), a base or a carrier may also be included. As the base or carrier, for example, cellulose derivatives such as ethyl cellulose, hydroxypropyl cellulose, and hydroxypropylmethyl cellulose; polyvinylpyrrolidone; carrageenan; polyvinylpyrrolidone; Vinyl butyral; polyethylene glycol; such as ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol monopropyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol Glycol ethers such as alcohol monopropyl ether, diethylene glycol monobutyl ether, propylene glycol monoethyl ether, propylene glycol monopropyl ether, dipropylene glycol monoethyl ether, and dipropylene glycol monopropyl ether; or lithium dimethyldistearyl ammonium Organic modified clay minerals such as bentonite. One type or two or more types of bases or carriers can be used.

[添加劑] 本發明之油中水型外用組成物中,在無損外觀穩定性及黏度等品質且無損本發明的效果之量及質的範圍內,可視需要調配於醫藥品、準藥品或化妝品領域中一般用作外用劑之成分之各種成分,例如胺基酸、刺激減輕劑、增黏劑、防腐劑、紫外線吸收劑、紫外線防禦劑、著色劑、分散劑、追加之pH值調整劑、香料等。再者,這些成分可單獨調配一種或任意調配兩種以上。 [additive] In the water-in-oil type composition for external use of the present invention, it can be formulated for general use in the field of pharmaceuticals, quasi-drugs, or cosmetics as needed within the range of quantity and quality that does not impair the appearance, stability, viscosity, etc., and does not impair the effects of the present invention. Various components used as components of external preparations, such as amino acids, irritation reducing agents, thickening agents, preservatives, ultraviolet absorbers, ultraviolet protection agents, colorants, dispersants, additional pH adjusters, fragrances, etc. In addition, these components can be compounded individually by 1 type or arbitrarily compounded 2 or more types.

[製造方法] 本發明之油中水型外用組成物之製造方法並無特別限定,乳化時的攪拌方法、乳化溫度、油相與水相之投入順序、投入速度等可適宜設定。 [Manufacturing method] The production method of the water-in-oil type composition for external use of the present invention is not particularly limited, and the stirring method during emulsification, the emulsification temperature, the order of adding the oil phase and the water phase, and the speed of adding can be appropriately set.

具體而言,可例舉視需要分別準備加熱溶解後混合之油相及水相,於室溫下向油相中緩慢地加入水相,藉由均質機等機械攪拌力進行乳化之方法等,但並不特別限定於這些方法。Specifically, if necessary, the oil phase and the water phase which are mixed after heating and dissolving are prepared separately, the water phase is slowly added to the oil phase at room temperature, and the method of emulsifying with a mechanical stirring force such as a homogenizer, etc. can be mentioned. However, it is not particularly limited to these methods.

[製劑形態] 本發明之油中水型外用組成物可與醫藥品、準藥品、或化妝品中通常所使用之基劑或載體、及視需要之添加劑一起混合,製成醫藥品、準藥品、或化妝品用之油中水型外用組成物。 [Preparation form] The water-in-oil type composition for external use of the present invention can be mixed with bases or carriers commonly used in pharmaceuticals, quasi-drugs, or cosmetics, and additives as needed to make pharmaceuticals, quasi-drugs, or cosmetics A water-in-oil composition for external use.

醫藥品用之油中水型外用組成物之形態並無特別限定,例如可例舉:液劑、懸浮劑、乳劑、乳霜劑、軟膏劑、凝膠劑、擦劑、洗劑、貼附劑及氣溶膠劑等。這些製劑可依據日本藥典第十五次修訂製劑總則所記載之方法等進行製造。當中,較佳為液劑、懸浮劑、乳劑、乳霜劑、軟膏劑、凝膠劑、洗劑、貼附劑,更佳為乳霜劑、乳劑、軟膏劑、洗劑及凝膠劑。The form of the water-in-oil type composition for pharmaceuticals is not particularly limited, for example, liquid, suspension, emulsion, cream, ointment, gel, liniment, lotion, patch Agents and aerosol agents, etc. These preparations can be produced in accordance with the methods described in the fifteenth revision of the Japanese Pharmacopoeia General Rules for Preparations, etc. Among them, solutions, suspensions, emulsions, creams, ointments, gels, lotions, and patches are preferred, and creams, emulsions, ointments, lotions, and gels are more preferred.

於製成準藥品或化妝品用之油中水型外用組成物之情形時,亦可製成與上述醫藥品同樣之形態。另外,除此以外,亦可例舉:棒劑、及不織布中含浸有藥液之片劑等。當中,較佳為液劑、懸浮劑、乳劑、乳霜劑、軟膏劑、凝膠劑、洗劑、棒劑及片劑,更佳為乳霜劑、乳劑、軟膏劑、凝膠劑或洗劑。When it is made into a water-in-oil type external composition for quasi-drugs or cosmetics, it can also be made into the same form as the above-mentioned medicines. Moreover, in addition to this, the tablet which impregnated the liquid medicine in a stick, and a nonwoven fabric, etc. are also mentioned. Among them, liquid preparations, suspension preparations, emulsions, creams, ointments, gels, lotions, sticks and tablets are preferred, and creams, emulsions, ointments, gels or washes are more preferred. agent.

本發明之油中水型外用組成物包含油相及水相,會發生乳化,典型地可採取乳霜劑或乳液等形態。The water-in-oil composition for external use of the present invention includes an oil phase and a water phase, which will be emulsified, and typically take the form of a cream or emulsion.

作為製成準藥品或化妝品用之油中水型外用組成物之情形時的用途,具體而言,例如可例舉:如化妝水、乳液、凝膠、乳霜、美容液、防曬用化妝品、敷劑、面膜、護手霜、及身體乳之類的基礎化妝品;以及粉餅、隔離等面部彩妝用化妝品、口紅、唇膏、唇彩、唇線筆等口唇化妝品等。As the use when it is prepared as a water-in-oil type external composition for quasi-drugs or cosmetics, specific examples include lotion, lotion, gel, cream, beauty essence, sunscreen cosmetics, Basic cosmetics such as compresses, facial masks, hand creams, and body lotions; and cosmetics for face makeup such as powders and primers, lip cosmetics such as lipsticks, lip balms, lip glosses, and lip liners.

本發明中的油相與水相的質量比可適宜設定,並無限定,就獲得更良好的穩定性及使用感之方面而言,較佳為油相:水相=1:9至6:4。The mass ratio of the oil phase and the water phase in the present invention can be appropriately set without limitation. In terms of obtaining better stability and feeling of use, the oil phase:water phase=1:9 to 6: 4.

[容器] 本發明之油中水型外用組成物可收容於根據使用目的及用途適宜選擇之形狀、材質之容器中而使用。作為具體的容器,例如可例示:噴霧型、瓶型、管型、罐型、滴管型、分注器型、棒型、小袋(pouch)、及企鵝包(CHEER PACK)等。 [container] The water-in-oil type composition for external use of the present invention can be accommodated in a container of a shape and material appropriately selected according to the purpose and application. Specific examples of containers include spray type, bottle type, tube type, can type, dropper type, dispenser type, stick type, pouch, and penguin pack (CHEER PACK).

另外,作為容器的材質,可例示:聚對苯二甲酸乙二酯、聚丙烯、聚乙烯(HDPE(High Density Polyethylene;高密度聚乙烯)、LDPE(Low Density Polyethylene;低密度聚乙烯)、LLDPE(Linear Low Density Polyethylene;線性低密度聚乙烯)等)、ABS(Acrylonitrile Butadiene Styrene;丙烯腈-丁二烯-苯乙烯)樹脂、乙烯乙烯醇樹脂、聚苯乙烯、玻璃、及金屬(鋁等)等。另外,對於這些材料,可考慮強度、柔軟性、耐候性、或成分的穩定性等,進行各種塗佈處理,或將這些材料例如混合等而組合,或進行積層,從而用作容器材料。In addition, examples of the material of the container include polyethylene terephthalate, polypropylene, polyethylene (HDPE (High Density Polyethylene; high-density polyethylene), LDPE (Low Density Polyethylene; low-density polyethylene), LLDPE (Linear Low Density Polyethylene; linear low density polyethylene), etc.), ABS (Acrylonitrile Butadiene Styrene; acrylonitrile-butadiene-styrene) resin, ethylene vinyl alcohol resin, polystyrene, glass, and metal (aluminum, etc.) wait. In addition, these materials can be used as container materials by performing various coating treatments in consideration of strength, flexibility, weather resistance, or component stability, or by combining or laminating these materials, for example, by mixing.

[緩和皮膚刺激之方法] 另外,本發明亦包含緩和含有(A)抗壞血酸以及或是其鹽之油中水型外用組成物之皮膚刺激之方法。根據本發明,藉由製成含有(A)選自由抗壞血酸及抗壞血酸之鹽所組成之群組中的至少一種、(B)丙二醇、(C)油分、及(D)聚矽氧系界面活性劑之油中水型外用組成物,能夠緩和油中水型外用組成物之皮膚刺激,因此能夠製成低刺激性之油中水型外用組成物。此處,皮膚刺激抑制方法中的各成分的含量、比率、其他成分等條件係依據[油中水型外用組成物]中所記載之內容。 [How to relieve skin irritation] In addition, the present invention also includes a method for alleviating skin irritation of a water-in-oil type external composition containing (A) ascorbic acid and a salt thereof. According to the present invention, by preparing (A) at least one selected from the group consisting of ascorbic acid and ascorbic acid salts, (B) propylene glycol, (C) oil, and (D) polysiloxane-based surfactants The water-in-oil type composition for external use can alleviate the skin irritation of the water-in-oil type composition for external use, so it can be made into a water-in-oil type composition for external use with low irritation. Here, conditions such as the content, ratio, and other components of each component in the skin irritation suppression method are based on the content described in [water-in-oil type composition for external use].

[提升穩定性之方法] 另外,本發明亦包含提升含有(A)抗壞血酸以及或是其鹽之油中水型外用組成物的穩定性之方法。根據本發明,藉由使含有(A)選自由抗壞血酸及抗壞血酸之鹽所組成之群組中的至少一種、(C)油分、及(D)聚矽氧系界面活性劑之油中水型外用組成物與(B)丙二醇共存,能夠提升油中水型外用組成物的穩定性。此處,提升穩定性之方法中的各成分的含量、比率、其他成分等條件係依據[油中水型外用組成物]中所記載之內容。 [How to improve stability] In addition, the present invention also includes a method for improving the stability of the water-in-oil composition for external use containing (A) ascorbic acid and its salt. According to the present invention, the water-in-oil type external application containing (A) at least one selected from the group consisting of ascorbic acid and ascorbic acid salts, (C) oil, and (D) polysiloxane-based surfactant The coexistence of the composition and (B) propylene glycol can improve the stability of the water-in-oil composition for external use. Here, the content, ratio, and other conditions of each component in the method of improving stability are based on the content described in [Water-in-Oil Type Composition for External Use].

[用途] 本發明之油中水型外用組成物尤其作為美白劑、抗炎劑、抗老化劑有效,例如具有青春痘預防或治療、抗氧化之作用。進而,可用於以美白、抗皺、抗老化為目的之製品。藉由應用於皮膚,有時會發揮出皮膚的透明感提高、保持濕潤、肌理平整、抑制粗糙之效果。進而,有時亦發揮使毛孔不顯著、調整肌膚保濕等效果,除此以外,亦可用於黃褐斑之預防或治療。 [use] The water-in-oil type external composition of the present invention is especially effective as a whitening agent, anti-inflammatory agent, and anti-aging agent, for example, it has the effect of preventing or treating acne and anti-oxidation. Furthermore, it can be used in products aimed at whitening, anti-wrinkle, and anti-aging. When applied to the skin, it can sometimes exert the effects of improving the transparency of the skin, maintaining moisture, smoothing the texture, and suppressing roughness. Furthermore, sometimes it also exerts effects such as making pores less conspicuous, regulating skin moisture, etc. In addition, it can also be used for the prevention or treatment of chloasma.

就對皮膚之作用效果而言,本發明較佳為用於作為皮膚外用劑(外皮用製劑)所應用之製品。本發明之油中水型組成物可根據用途等每天一次至分為數次,以公知或慣用之用法、用量來使用。In terms of effects on the skin, the present invention is preferably a product used as an external preparation for the skin (preparation for the skin). The water-in-oil composition of the present invention can be divided into several times a day according to the application, etc., and used in known or customary usage and dosage.

本發明係關於:(1)一種油中水型外用組成物,含有:(A)選自由抗壞血酸及抗壞血酸之鹽所組成之群組中的至少一種;(B)丙二醇;(C)油分;及(D)聚矽氧系界面活性劑。 此處,可例舉以下態樣。 The present invention relates to: (1) a water-in-oil composition for external use, containing: (A) at least one selected from the group consisting of ascorbic acid and ascorbic acid salts; (B) propylene glycol; (C) oil; and (D) Polysiloxane-based surfactant. Here, the following aspects can be exemplified.

(2)如上述(1)之油中水型外用組成物,其中前述(A)選自由抗壞血酸及抗壞血酸之鹽所組成之群組中的至少一種的含量為5質量%至15質量%。 (3)如(1)或(2)所記載之油中水型外用組成物,其中前述(B)丙二醇的含量為15質量%至80質量%。 (4)如(1)至(3)中任一項所記載之油中水型外用組成物,其中前述(C)油分的含量為1質量%至40質量%。 (5)如(1)至(4)中任一項所記載之油中水型外用組成物,其中前述(D)成分的含量為1質量%至30質量%。 (6)如(5)所記載之油中水型外用組成物,其中前述(D)成分的含量為1質量%至5質量%。 (7)如(1)至(6)中任一項所記載之油中水型外用組成物,進而含有乙醇。 (8)如(1)至(7)中任一項所記載之油中水型外用組成物,進而含有(B)成分以外的多元醇。 (9)如(8)所記載之油中水型外用組成物,其中(B)成分於前述油中水型外用組成物中的全部多元醇中所佔之比例為30質量%以上。 (10)如(1)至(9)中任一項所記載之油中水型外用組成物,其為乳霜劑或乳液。 (11)如(1)至(10)中任一項所記載之油中水型組成物,其中相對於(A)成分的總含量1質量份,水為0.05質量份至3質量份。 (12) 如(1)至(10)中任一項所記載之油中水型組成物,其中相對於(A)成分的總含量1質量份,(B)成分為4質量份至35質量份。 [實施例] (2) The water-in-oil type external composition according to (1) above, wherein the content of at least one selected from the group consisting of ascorbic acid and salts of ascorbic acid is 5% to 15% by mass. (3) The water-in-oil composition for external use as described in (1) or (2), wherein the content of the aforementioned (B) propylene glycol is 15% by mass to 80% by mass. (4) The water-in-oil composition for external use as described in any one of (1) to (3), wherein the content of the aforementioned (C) oil component is 1% by mass to 40% by mass. (5) The water-in-oil type external composition as described in any one of (1)-(4) whose content of the said (D) component is 1 mass % - 30 mass %. (6) The water-in-oil type external use composition as described in (5) whose content of the said (D) component is 1 mass % - 5 mass %. (7) The water-in-oil composition for external use as described in any one of (1) to (6), which further contains ethanol. (8) The water-in-oil composition for external use as described in any one of (1) to (7), which further contains a polyhydric alcohol other than the (B) component. (9) The water-in-oil composition for external use as described in (8), wherein the ratio of the component (B) to all the polyols in the water-in-oil composition for external use is 30% by mass or more. (10) The water-in-oil composition for external use as described in any one of (1) to (9), which is a cream or an emulsion. (11) The water-in-oil composition as described in any one of (1) to (10), wherein water is 0.05 to 3 parts by mass relative to 1 part by mass of the total content of the component (A). (12) The water-in-oil composition as described in any one of (1) to (10), wherein the component (B) is 4 to 35 parts by mass relative to 1 part by mass of the total content of the component (A) share. [Example]

其次,藉由實施例具體地說明本發明,但本發明並不限定於以下之實施例。再者,表中的各成分量的單位為質量%。Next, although an Example demonstrates this invention concretely, this invention is not limited to a following Example. In addition, the unit of each component quantity in a table|surface is mass %.

依據常規方法製備表1至表4中所示之組成的組成物。表中,只要無特別說明,則數值表示質量%。Compositions with the compositions shown in Table 1 to Table 4 were prepared according to conventional methods. In the table, unless otherwise specified, the numerical values represent % by mass.

[細胞毒殺性試驗] 製備比較例及實施例之組成物後,利用三維培養皮膚實施細胞毒殺性試驗。 於人三維培養表皮LabCyte EPI-MODEL24(Japan Tissue Engineering公司)的透過多孔性膜(transwell)(24孔板用透過多孔性膜)的下部所附帶之專用的檢測培養基中每孔加入0.5mL,於37℃(5%至10%CO2)預培養18小時至22小時。 [Cytotoxicity test] After preparing the compositions of Comparative Examples and Examples, a cytotoxicity test was carried out using three-dimensional cultured skin. Add 0.5mL to each well of the special detection medium attached to the lower part of the transwell (transwell) (transwell for 24-well plate) of human three-dimensional culture epidermis LabCyte EPI-MODEL24 (Japan Tissue Engineering company), Pre-incubate at 37°C (5% to 10% CO2) for 18 hours to 22 hours.

然後,將專用之檢測培養基置換成0.5mLPBS(phosphate buffered saline,磷酸緩衝生理鹽水),於37℃之恆溫槽上預培養30分鐘。進而,將PBS置換成等量的新鮮的PBS,於細胞的上部直接添加各組成物0.1mL,並靜置30分鐘。Then, the special detection medium was replaced with 0.5mL PBS (phosphate buffered saline, phosphate buffered saline), and pre-incubated on a constant temperature bath at 37°C for 30 minutes. Furthermore, the PBS was replaced with an equivalent amount of fresh PBS, 0.1 mL of each composition was added directly on top of the cells, and the cells were left to stand for 30 minutes.

其次,利用PBS將透過多孔性膜仔細地洗淨後,將透過多孔性膜的下部的PBS置換成0.5mL之(3-(4,5-二甲基噻唑-2-基)-2,5-二苯基溴化四唑溶液(MTT溶液)。然後,於37℃培養3小時,於遮光下培養。MTT溶液係藉由將0.5mg之MTT溶解於1mL之PBS中而製備。然後,將自透過多孔性膜剝離之人三維培養表皮移至微管,加入0.3mL之異丙醇後,於陰涼處培養15小時以上,進行色素萃取。針對所萃取之色素,使用電暈電氣股份有限公司的微盤讀取器來測定吸光度(測定波長:570nm、650nm)。基於實測值,使用下述式算出細胞存活率,評價組成物的細胞毒殺性。測定值=[(各組成物處置組對於570nm之吸光度)-(各組成物處置組對於650nm之吸光度)]-[(異丙醇對於570nm之吸光度)-(異丙醇對於650nm之吸光度)]細胞存活率(%)=100×(各組成物處置組的測定值)/(PBS處置組的測定值)細胞存活率改善率(%)=100×{(基於各組成物的存活率/基於基準組成物的存活率)-1}Next, after carefully washing the permeated porous membrane with PBS, the PBS at the lower part of the permeated porous membrane was replaced with 0.5 mL of (3-(4,5-dimethylthiazol-2-yl)-2,5 -diphenyltetrazolium bromide solution (MTT solution). Then, cultivated at 37° C. for 3 hours and cultivated under light-shielding. The MTT solution was prepared by dissolving 0.5 mg of MTT in 1 mL of PBS. Then, the Transfer the human three-dimensional cultured epidermis peeled through the porous membrane to a microtube, add 0.3mL of isopropanol, and incubate in a cool place for more than 15 hours for pigment extraction. For the extracted pigment, use Corona Electric Co., Ltd. Measure the absorbance (measurement wavelength: 570nm, 650nm) with a microdisk reader. Based on the measured value, use the following formula to calculate the cell survival rate and evaluate the cytotoxicity of the composition. Measured value=[(each composition treatment group for Absorbance at 570nm) - (Absorbance at 650nm of each composition treatment group)] - [(Absorbance of isopropanol at 570nm) - (Absorbance of isopropanol at 650nm)] Cell survival rate (%) = 100 × (each The measured value of the composition treatment group) / (the measured value of the PBS treatment group) the improvement rate of the cell survival rate (%) = 100 × {(the survival rate based on each composition/the survival rate based on the reference composition)-1}

實施例、參考例、及比較例的組成物的評價結果示於表1至表3。The evaluation results of the compositions of Examples, Reference Examples, and Comparative Examples are shown in Tables 1 to 3.

[表1] [%表示質量%] 比較例1-1 實施例1-1 成分名 調配量(%) 調配量(%) 1,3-丙二醇 - 50 二乙二醇單乙醚 50 - 抗壞血酸 10 10 乙醇 15 15.5 十甲基環五矽氧烷與交聯型甲基聚矽氧烷之混合液 1.5 1.5 交聯型聚醚改質聚矽氧混合物與甲基聚矽氧烷之混合物 3 3 鯨蠟基PEG/PPG-10/1二甲聚矽氧烷 3 3 甲基聚矽氧烷 17 17 純化水 10 10 合計 100 100 以比較例1為基準的存活率改善率(%) / 55.8 [Table 1] [% represents mass%] Comparative example 1-1 Example 1-1 ingredient name Deployment volume (%) Deployment volume (%) 1,3-Propanediol - 50 Diethylene glycol monoethyl ether 50 - ascorbic acid 10 10 ethanol 15 15.5 Mixture of decamethylcyclopentasiloxane and cross-linked methylpolysiloxane 1.5 1.5 Mixture of cross-linked polyether modified polysiloxane and methylpolysiloxane 3 3 Cetyl PEG/PPG-10/1 Dimethicone 3 3 Methylpolysiloxane 17 17 purified water 10 10 total 100 100 Survival improvement rate based on Comparative Example 1 (%) / 55.8

於表1中,比較例1-1及實施例1-1為油中水型組成物。如表1所示,相對於使用二乙二醇單乙醚之比較例1-1,使用1,3-丙二醇之實施例1-1可見細胞存活率之改善。In Table 1, Comparative Example 1-1 and Example 1-1 are water-in-oil compositions. As shown in Table 1, compared with Comparative Example 1-1 using diethylene glycol monoethyl ether, the cell viability was improved in Example 1-1 using 1,3-propanediol.

[表2] [%表示質量%] 比較例2-1 比較例2-2 實施例2-1 實施例2-2 成分名 調配量(%) 調配量(%) 調配量(%) 調配量(%) 1,3-丙二醇 50 50 50 50 抗壞血酸 10 10 10 10 乙醇 5 5 5 5 甘油 5.5 5.5 5.5 5.5 1,3-丁二醇 19.5 29.5 - 10 十甲基環五矽氧烷與交聯型甲基聚矽氧烷之混合液 - - 1.5 1.5 交聯型聚醚改質聚矽氧混合物與甲基聚矽氧烷之混合物 - - 3 3 鯨蠟基PEG/PPG-10/1二甲聚矽氧烷 - - 3 3 甲基聚矽氧烷 - - 12 12 純化水 10 - 10 - 合計 100 100 100 100 以比較例2-1為基準之細胞存活率改善率(%) / -7.4 9.2 10.3 以比較例2-2為基準之細胞存活率改善率(%) / / 17.9 19.1 [Table 2] [% represents mass%] Comparative example 2-1 Comparative example 2-2 Example 2-1 Example 2-2 ingredient name Deployment volume (%) Deployment volume (%) Deployment volume (%) Deployment volume (%) 1,3-Propanediol 50 50 50 50 ascorbic acid 10 10 10 10 ethanol 5 5 5 5 glycerin 5.5 5.5 5.5 5.5 1,3-Butanediol 19.5 29.5 - 10 Mixture of decamethylcyclopentasiloxane and cross-linked methylpolysiloxane - - 1.5 1.5 Mixture of cross-linked polyether modified polysiloxane and methylpolysiloxane - - 3 3 Cetyl PEG/PPG-10/1 Dimethicone - - 3 3 Methylpolysiloxane - - 12 12 purified water 10 - 10 - total 100 100 100 100 Improvement rate of cell viability based on comparative example 2-1 (%) / -7.4 9.2 10.3 The improvement rate of cell viability based on Comparative Example 2-2 (%) / / 17.9 19.1

於表2中,比較例2-1及比較例2-2係由水性成分所構成之美容液,實施例2-1及實施例2-2係油中水型組成物。如表2所示,若使用1,3-丙二醇,則尤其是於未調配水之美容液中,細胞存活率降低。使用1,3-丙二醇來製成油中水型組成物之乳霜劑時,細胞存活率得到改善。再者,未調配水之乳霜劑顯示出進一步得到改善之細胞存活率。In Table 2, Comparative Example 2-1 and Comparative Example 2-2 are beauty lotions composed of water-based ingredients, and Example 2-1 and Example 2-2 are water-in-oil compositions. As shown in Table 2, when 1,3-propanediol was used, the cell survival rate decreased, especially in the cosmetic serum without water. Cell viability was improved when 1,3-propanediol was used to make water-in-oil creams. Furthermore, the cream formulation without water showed further improved cell viability.

[表3] [%表示質量%] 比較例3-1 實施例3-1 成分名 調配量(%) 調配量(%) 3-O-乙基抗壞血酸 0.5 0.5 1,3-丙二醇 - 60 1,2-丙二醇 60 - 抗壞血酸 10 10 乙醇 5 5 十甲基環五矽氧烷與交聯型甲基聚矽氧烷之混合液 1.5 1.5 交聯型聚醚改質聚矽氧混合物與甲基聚矽氧烷之混合物 3 3 鯨蠟基PEG/PPG-10/1二甲聚矽氧烷 3 3 甲基聚矽氧烷 17 17 純化水 - - 合計 100 100 以比較例3-1為基準時的存活率改善率 / 29.2 [Table 3] [% represents mass%] Comparative example 3-1 Example 3-1 ingredient name Deployment volume (%) Deployment volume (%) 3-O-ethyl ascorbic acid 0.5 0.5 1,3-Propanediol - 60 1,2-propanediol 60 - ascorbic acid 10 10 ethanol 5 5 Mixture of decamethylcyclopentasiloxane and cross-linked methylpolysiloxane 1.5 1.5 Mixture of cross-linked polyether modified polysiloxane and methylpolysiloxane 3 3 Cetyl PEG/PPG-10/1 Dimethicone 3 3 Methylpolysiloxane 17 17 purified water - - total 100 100 Survival rate improvement rate based on Comparative Example 3-1 / 29.2

根據表3之結果,可知與調配有1,2-丙二醇之油中水型組成物之乳霜劑相比,調配有1,3-丙二醇之油中水型組成物之乳霜劑中可見細胞存活率之改善。根據以上內容,可知藉由製成調配有1,3-丙二醇之油中水型組成物之乳霜劑,實現了該組成物之皮膚刺激之緩和。According to the results in Table 3, it can be seen that compared with the cream formulated with 1,2-propanediol water-in-oil composition, cells can be seen in the cream formulated with 1,3-propanediol water-in-oil composition Improvement in survival rate. From the above, it can be seen that the skin irritation of the composition was relieved by preparing a cream containing a water-in-oil composition containing 1,3-propanediol.

[穩定性試驗] 製備比較例及實施例之組成物後,於室溫靜置一天而確認初始性狀。然後,於60℃之恆溫槽中靜置,確認2週後、3週後的製劑的狀態。對於60℃保管後的製劑的狀態,分別自60℃之恆溫槽中取出後,於25℃恆溫化而根據製劑的外觀進行性狀觀察。 [Stability test] After preparing the compositions of Comparative Examples and Examples, they were left at room temperature for one day to confirm the initial properties. Then, it was left still in a 60 degreeC thermostat, and the state of the formulation after 2 weeks and 3 weeks was confirmed. The state of the preparation after storage at 60°C was taken out from the constant temperature tank at 60°C, and then was thermostated at 25°C to observe the properties from the appearance of the preparation.

實施例、參考例、及比較例的組成物的評價結果示於表4。 [表4] [%表示質量%]   實施例4-1 實施例4-2 實施例4-3 比較例4-1 比較例4-2 成分名 調配量(%) 調配量(%) 調配量(%) 調配量(%) 調配量(%) 1,3-丙二醇 50 20 50 - - 1,2-丙二醇 - - - 50 - 二丙二醇 - - - - 50 1,3-丁二醇 - 30 - - - 抗壞血酸 5 5 3 5 3 乙醇 5 5 5 5 5 十甲基環五矽氧烷與交聯型甲基聚矽氧烷之混合液 2 2 2 2 2 (二甲聚矽氧烷/(PEG-10/15))交聯聚合物與二甲聚矽氧烷之混合物 2 2 2 2 2 二甲基二硬脂基銨鋰膨潤石與十甲基環五矽氧烷與聚氧乙烯-甲基聚矽氧烷共聚物之混合物 8 8 8 8 8 甲基聚矽氧烷 18 18 20 18 20 純化水 10 10 10 10 10 合計 100 100 100 100 100 性狀 製備第二天 未分離 未分離 未分離 未分離 分離 60℃1週後 未分離 未分離 未分離 未分離 - 60℃3週後 未分離 未分離 未分離 分離 - Table 4 shows the evaluation results of the compositions of Examples, Reference Examples, and Comparative Examples. [Table 4] [% represents mass%] Example 4-1 Example 4-2 Example 4-3 Comparative example 4-1 Comparative example 4-2 ingredient name Deployment volume (%) Deployment volume (%) Deployment volume (%) Deployment volume (%) Deployment volume (%) 1,3-Propanediol 50 20 50 - - 1,2-propanediol - - - 50 - Dipropylene glycol - - - - 50 1,3-Butanediol - 30 - - - ascorbic acid 5 5 3 5 3 ethanol 5 5 5 5 5 Mixture of decamethylcyclopentasiloxane and cross-linked methylpolysiloxane 2 2 2 2 2 Mixture of (Dimethicone/(PEG-10/15)) Crosslinked Polymer and Dimethicone 2 2 2 2 2 Dimethyldistearyl ammonium lithium bentonite mixture with decamethylcyclopentasiloxane and polyoxyethylene-methylpolysiloxane copolymer 8 8 8 8 8 Methylpolysiloxane 18 18 20 18 20 purified water 10 10 10 10 10 total 100 100 100 100 100 character Prepare the next day not separated not separated not separated not separated separate After 1 week at 60°C not separated not separated not separated not separated - After 3 weeks at 60°C not separated not separated not separated separate -

如表4所示,於調配有1,3-丙二醇之情形時,獲得了穩定的油中水型外用組成物。另一方面,如比較例1所示,於未調配1,3-丙二醇而僅調配有1,2-丙二醇之組成物中,於60℃下保存3週後確認到分離。再者,於比較例1之組成物中,自於60℃保存2週後可見分離傾向。如比較例2所示,於僅調配有二丙二醇之組成物中,於製備第二天確認到分離。As shown in Table 4, when 1,3-propanediol was formulated, a stable water-in-oil type external composition was obtained. On the other hand, as shown in Comparative Example 1, separation was confirmed after storage at 60° C. for 3 weeks in a composition containing only 1,2-propanediol without 1,3-propanediol. Furthermore, in the composition of Comparative Example 1, a separation tendency was observed after storage at 60° C. for 2 weeks. As shown in Comparative Example 2, in the composition containing only dipropylene glycol, separation was confirmed on the second day of preparation.

[配方例] 於下述表5及表6中顯示配方例(製劑例1至製劑例10)。配方例均為乳霜劑,配方例中的含量均為質量%。再者,表6係表5之延續。 [Recipe Example] Formulation examples (formulation example 1 to formulation example 10) are shown in following Table 5 and Table 6. The formulation examples are all creams, and the contents in the formulation examples are all mass %. Furthermore, Table 6 is a continuation of Table 5.

[表5] 製劑例1 製劑例2 製劑例3 製劑例4 製劑例5 製劑例6 製劑例7 製劑例8 製劑例9 製劑例10 乳霜 乳霜 乳霜 乳霜 乳霜 乳霜 乳霜 乳霜 防曬霜 防曬霜 抗壞血酸 5 5 7 10 3 10 12 15 5 15 1,3-丙二醇 30 50 40 30 50 60 30 30 30 50 角鯊烷 5 8 3 甘油三(辛酸/癸酸)酯 1.5 3 1 白芒花籽油 3 5 2 2 氫化油 0.5 1 2-乙基己酸鯨蠟酯 4 5 甲基聚矽氧烷 5 8 4 10 5 3 15 20 凡士林 2 2 1 牛油樹油酯 3 1 甘油三(辛酸/癸酸/肉豆蔻酸/硬脂酸)酯 0.5 1 硬脂酸 1 0.3 鯨蠟醇 0.5 俞樹醇 0.5 0.5 異壬酸異壬酯 1 2 液態石蠟 2 5 十甲基環五矽氧烷 1 3 2 交聯型甲基聚矽氧烷 2 1 4 交聯型聚醚改質聚矽氧混合物 3 2 0.5 鯨蠟基PEG/PPG-10/1二甲聚矽氧烷 3 3 2.5 高聚合甲基聚矽氧烷(1) 5 2 月桂基PEG-9聚二甲基矽烷氧基乙基二甲聚矽氧烷 2 1 PEG/PPG-20/22丁醚二甲聚矽氧烷 2 (二甲聚矽氧烷/(PEG-10/15))交聯聚合物 1 3 甲基苯基聚矽氧烷 0.5 2 0.8 二甲基二硬脂基銨鋰膨潤石 2 3 1 聚氧乙烯-甲基聚矽氧烷共聚物 3 6 4 無水乙醇 5 7 10 10 12 5 3 5 10 7 3-O-乙基抗壞血酸 0.5 1 0.5 0.3 0.5 0.5 甘油 17.52 29.7 1,3-丁二醇 34.3 6.75 0.2 1,2-丙二醇 8.04 13.23 戊二醇 3 己二醇 2 二丙二醇 6.35 1.69 26.7 對羥基苯甲酸甲酯 0.2 0.25 焦亞硫酸鈉 0.02 0.03 苯氧基乙醇 0.3 0.3 0.2 氯苯甘醚 0.1 甘油單2-乙基己醚 0.05 0.1 羧基乙烯基聚合物 0.2 0.15 羥基丙基甲基纖維素 0.05 0.1 聚氧乙烯山梨醇酐異硬脂酸酯(20E.O.) 2 1.5 二甘油三異硬脂酸酯 0.5 3 2 大豆蛋白水解物 0.01 0.1 水解膠原蛋白 0.02 0.05 神經醯胺2 0.005 0.05 神經醯胺3 0.01 0.05 甘油葡萄糖苷 1 薏苡仁萃取物 0.02 [表6] 朝鮮薊萃取物 0.05 香菊萃取物 0.01 刺蘼萃取物 0.04 迷迭香萃取物 0.01 檸檬萃取物 0.02 葡萄柚萃取物 0.04 0.01 酵母萃取物 0.01 0.01 d-δ-生育酚 0.05 0.1 0.1 蜂王漿萃取物 0.06 檸檬酸 適量 適量 適量 檸檬酸鈉 適量 適量 適量 乙二胺四乙酸二鈉 0.1 0.05 0.1 0.05 0.1 0.05 0.1 對甲氧基肉桂酸2-乙基己酯 2 水楊酸2-乙基己酯 0.5 4-第三丁基-4'-甲氧基二苯甲醯甲烷 1.5 苯基苯并咪唑磺酸 0.2 二乙胺基羥基苯甲醯苯甲酸己酯 2 雙乙基己氧基苯基甲氧基苯基三嗪 2 純化水 5 3 10 5 3 10 5 3 8 10 合計 100 100 100 100 100 100 100 100 100 100 [table 5] Preparation Example 1 Preparation example 2 Preparation example 3 Preparation Example 4 Preparation Example 5 Preparation example 6 Preparation Example 7 Preparation Example 8 Preparation Example 9 Preparation Example 10 cream cream cream cream cream cream cream cream sunscreen sunscreen ascorbic acid 5 5 7 10 3 10 12 15 5 15 1,3-Propanediol 30 50 40 30 50 60 30 30 30 50 squalane 5 8 3 Glyceryl tri(caprylic/capric) ester 1.5 3 1 Mangosteen Seed Oil 3 5 2 2 hydrogenated oil 0.5 1 Cetyl 2-Ethylhexanoate 4 5 Methylpolysiloxane 5 8 4 10 5 3 15 20 vaseline 2 2 1 shea butter 3 1 Glyceryl Tri(caprylic/capric/myristic/stearic acid) 0.5 1 stearic acid 1 0.3 cetyl alcohol 0.5 eucalyptus 0.5 0.5 Isononyl isononanoate 1 2 liquid paraffin 2 5 Decamethylcyclopentasiloxane 1 3 2 Cross-linked methylpolysiloxane 2 1 4 Cross-linked polyether modified polysiloxane mixture 3 2 0.5 Cetyl PEG/PPG-10/1 Dimethicone 3 3 2.5 Highly Polymerized Methylpolysiloxane (1) 5 2 Lauryl PEG-9 Polydimethylsiloxyethyl Dimethicone 2 1 PEG/PPG-20/22 Butyl ether dimethicone 2 (Dimethicone/(PEG-10/15)) Crosspolymer 1 3 Methylphenyl polysiloxane 0.5 2 0.8 Dimethyldistearyl ammonium lithium bentonite 2 3 1 Polyoxyethylene-methyl polysiloxane copolymer 3 6 4 Absolute ethanol 5 7 10 10 12 5 3 5 10 7 3-O-ethyl ascorbic acid 0.5 1 0.5 0.3 0.5 0.5 glycerin 17.52 29.7 1,3-Butanediol 34.3 6.75 0.2 1,2-propanediol 8.04 13.23 Pentylene glycol 3 Hexylene glycol 2 Dipropylene glycol 6.35 1.69 26.7 Methylparaben 0.2 0.25 Sodium metabisulfite 0.02 0.03 Phenoxyethanol 0.3 0.3 0.2 Chlorphenesin 0.1 Glycerol mono-2-ethylhexyl ether 0.05 0.1 carboxy vinyl polymer 0.2 0.15 Hydroxypropyl Methyl Cellulose 0.05 0.1 Polyoxyethylene Sorbitan Isostearate (20E.O.) 2 1.5 Diglyceryl Triisostearate 0.5 3 2 Soy Protein Hydrolyzate 0.01 0.1 Hydrolyzed Collagen 0.02 0.05 Ceramide 2 0.005 0.05 Ceramide 3 0.01 0.05 glycerol glucoside 1 Coix Seed Extract 0.02 [Table 6] Artichoke Extract 0.05 Chrysanthemum Extract 0.01 thorn extract 0.04 rosemary extract 0.01 lemon extract 0.02 grapefruit extract 0.04 0.01 yeast extract 0.01 0.01 d-delta-tocopherol 0.05 0.1 0.1 Royal Jelly Extract 0.06 citric acid Appropriate amount Appropriate amount Appropriate amount Sodium citrate Appropriate amount Appropriate amount Appropriate amount Disodium edetate 0.1 0.05 0.1 0.05 0.1 0.05 0.1 2-Ethylhexyl p-methoxycinnamate 2 2-Ethylhexyl Salicylate 0.5 4-tert-butyl-4'-methoxydibenzoylmethane 1.5 Phenylbenzimidazole sulfonic acid 0.2 Diethylamino hydroxybenzoyl hexyl benzoate 2 Bisethylhexyloxyphenylmethoxyphenyltriazine 2 purified water 5 3 10 5 3 10 5 3 8 10 total 100 100 100 100 100 100 100 100 100 100

Claims (7)

一種油中水型外用組成物,含有: (A)選自由抗壞血酸及抗壞血酸之鹽所組成之群組中的至少一種; (B)丙二醇; (C)油分;及 (D)聚矽氧系界面活性劑。 A water-in-oil composition for external use, comprising: (A) At least one selected from the group consisting of ascorbic acid and salts of ascorbic acid; (B) propylene glycol; (C) oil content; and (D) Polysiloxane-based surfactant. 如請求項1所記載之油中水型外用組成物,其中前述(A)選自由抗壞血酸及抗壞血酸之鹽所組成之群組中的至少一種的含量為1質量%至30質量%。The water-in-oil composition for external use as described in Claim 1, wherein the content of at least one selected from the group consisting of ascorbic acid and ascorbic acid salts is 1% to 30% by mass. 如請求項1所記載之油中水型外用組成物,其中前述(B)丙二醇的含量為15質量%以上。The water-in-oil type composition for external use as described in claim 1, wherein the content of the aforementioned (B) propylene glycol is 15% by mass or more. 如請求項1所記載之油中水型外用組成物,其中水的含量為10質量%以下。The water-in-oil composition for external use as described in claim 1, wherein the water content is 10% by mass or less. 如請求項1所記載之油中水型外用組成物,其中前述(C)油分包含聚矽氧油。The water-in-oil type composition for external use as described in claim 1, wherein the aforementioned (C) oil component contains polysiloxane oil. 如請求項1所記載之油中水型外用組成物,進而含有低級醇。The water-in-oil type composition for external use as described in Claim 1 further contains lower alcohols. 一種緩和油中水型外用組成物之皮膚刺激之方法,係藉由使(A)選自由抗壞血酸及抗壞血酸之鹽所組成之群組中的至少一種、(B)丙二醇、及(C)油分共存,來緩和含有(A)選自由抗壞血酸及抗壞血酸之鹽所組成之群組中的至少一種之油中水型外用組成物之皮膚刺激。A method for relieving skin irritation of a water-in-oil type composition for external use, by making (A) at least one selected from the group consisting of ascorbic acid and a salt of ascorbic acid, (B) propylene glycol, and (C) an oil component coexist , to alleviate the skin irritation of the water-in-oil type external composition containing (A) at least one selected from the group consisting of ascorbic acid and ascorbic acid salts.
TW111137124A 2021-09-30 2022-09-30 Water-in-oil composition for external use containing ascorbic acid and/or its salt TWI813460B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021161636 2021-09-30
JP2021-161636 2021-09-30

Publications (2)

Publication Number Publication Date
TW202317091A true TW202317091A (en) 2023-05-01
TWI813460B TWI813460B (en) 2023-08-21

Family

ID=85782551

Family Applications (1)

Application Number Title Priority Date Filing Date
TW111137124A TWI813460B (en) 2021-09-30 2022-09-30 Water-in-oil composition for external use containing ascorbic acid and/or its salt

Country Status (3)

Country Link
JP (1) JPWO2023054168A1 (en)
TW (1) TWI813460B (en)
WO (1) WO2023054168A1 (en)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2742354B1 (en) * 1995-12-15 1998-01-23 Oreal STABLE W / O / W EMULSION CONTAINING A WATER SENSITIVE COSMETIC AND / OR DERMATOLOGICAL ACTIVE AGENT
US20020119954A1 (en) * 1999-01-06 2002-08-29 L'oreal, S.A. Composition containing stabilized ascorbic acid, and uses thereof
CN101316578A (en) * 2005-11-01 2008-12-03 陶氏康宁公司 Silicone vesicles containing actives
CN101584647B (en) * 2008-05-20 2012-10-31 赢创德固赛特种化学(上海)有限公司 Polylol-in-oil composition with high vitamin C content and preparation method thereof
CN105434181B (en) * 2015-12-30 2019-04-23 广州市科能化妆品科研有限公司 A kind of water-free skin care compositions of bilayer and preparation method thereof
US20210052481A1 (en) * 2017-12-27 2021-02-25 Rohto Pharmaceutical Co., Ltd. External composition containing ascorbic acid and/or salt thereof
CN112739342A (en) * 2018-09-25 2021-04-30 日本乐敦制药株式会社 Composition for external use containing ascorbic acid and/or salt thereof
WO2020138420A1 (en) * 2018-12-28 2020-07-02 ロート製薬株式会社 Water-in-oil emulsion composition containing nicotinamide
JP2020132631A (en) * 2019-02-15 2020-08-31 ロート製薬株式会社 External skin composition
US20210093539A1 (en) * 2019-09-30 2021-04-01 Concept Matrix Solutions Topical cosmetic

Also Published As

Publication number Publication date
JPWO2023054168A1 (en) 2023-04-06
WO2023054168A1 (en) 2023-04-06
TWI813460B (en) 2023-08-21

Similar Documents

Publication Publication Date Title
KR101962952B1 (en) Self-foaming cosmetic composition and method of preparing the same
EP0673642A1 (en) Solid lipophilic composition and process for its preparation
JP2008007428A (en) External skin wrinkling-preventing agent
JP7058943B2 (en) Oil-in-water emulsification composition
JP2011195510A (en) Oil-in-water type emulsified skin external composition
JP2012017318A (en) Liquid crystal and skin external preparation containing the same
KR20200056210A (en) Non-aqueous oil balm type cosmetics composition
JP5695388B2 (en) Oil-in-water emulsion composition
KR102359729B1 (en) Cosmetic Composition for Reducing Stickiness and Improving Transparency of Emulsion Formulation
JP2003048846A (en) Collagenase inhibitor and antiaging cosmetic
JP2001270807A (en) Translucent or transparent cosmetic
KR20150072797A (en) Composition comprising high concentration caffeines
KR101620294B1 (en) Cosmetic composition with high hardness which is possible for filling in room temperature
TWI813460B (en) Water-in-oil composition for external use containing ascorbic acid and/or its salt
TW202308591A (en) Cosmetic
JP2010270067A (en) Emulsion composition
JP2015137263A (en) Water-in-oil type emulsion composition and water-in-oil type emulsion cosmetic using the same
JP4653513B2 (en) Skin preparation
KR102175467B1 (en) Oil-in-water type emulsion composition and method for preparing thereof
KR101338503B1 (en) Cosmetic composition comprising weighting agent
JP2010030933A (en) Skin care preparation for external use
JP2001354510A (en) Oil-in-water type composition for external use
KR20160071744A (en) Thermo-sensitive color cosmetic composition and the method of producing the same
WO2015145602A1 (en) Composition useful as external preparation for skin or cosmetic preparation
KR102381622B1 (en) Stabilizing method of rice bran wax and cosmetic composition containing the stabilized rice bran wax